Key facts
- Gary B. Gordon has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $178,374.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Gary B. Gordon
- Location
- Rehovot, Israel
- Summary
- The estimated net worth of Gary B. Gordon is at least $178,374 dollars as of 18 May 2026. Gary B. Gordon is the Director of TriSalus Life Sciences, Inc. and owns shares of TriSalus Life Sciences, Inc. (TLSI) stock worth about $178.4K.
- Signature
- /s/ Mary Szela, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Gary B. Gordon and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: TriSalus Life Sciences, Inc. ($178,374).
- Past-year value change for that position: +$64,600.
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Gary B. Gordon
TLSI, TLSIW
Forms 3/4/5
TriSalus Life Sciences, Inc.
- Relationship
- Director
- Holdings value
- $178,374
- Past year net change
- +$64,600
- Change %
- +57%
- Report period
- 15 May 2026
AYLA
Forms 3/4/5
Old Ayala, Inc
- Relationship
- Chief Medical Officer
- Holdings value
- Past year net change
- Change %
- Report period
- 19 Jan 2023
Insider Transactions Reported by Gary B. Gordon:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.